![]() |
市場調查報告書
商品編碼
1954610
全球便攜式超音波市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Handheld Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球便攜式超音波市場規模為3.9729億美元,預計將從2026年的4.4828億美元成長至2034年的11.3143億美元,在預測期(2026-2034年)內年複合成長率高達12.27%。2025年,北美以41.07%的市場佔有率領先,顯著反映了即時診斷技術的廣泛應用。
便攜式超音波設備是緊湊便攜的成像診斷系統,可連接到智慧型手機、平板電腦或專用控制台。這些設備能夠幫助醫院、急診室、門診部甚至家庭醫療保健機構快速做出診斷決策。
市場概覽
心血管疾病、癌症和泌尿系統疾病等急性和慢性疾病的增加是推動市場成長的主要因素。根據世界衛生組織(WHO)統計,2022年全球新增癌症病例2000萬例,這清楚地表明人們對早期且易於獲取的診斷成像解決方案的需求日益成長。
此外,人口老化加劇也是推動需求成長的因素。根據美國人口與人口統計研究所統計,2022年美國 65 歲及以上人口為 5,800萬,預計到2050年將達到 8,200萬。隨著人口老化,慢性疾病的風險增加,因此對便攜式且經濟高效的影像工具的需求也隨之增加。
市場動態
市場驅動因素
慢性病和急性病病例增加
心血管疾病的增加顯著推動了便攜式超音波設備的普及。根據美國疾病管制與預防中心(CDC)(2024)統計,美國每年約有 80.5萬例心臟病發作。便攜式超音波系統的便攜性和即時影像功能使其成為急診和重症監護環境下心臟評估的理想選擇。
此外,人們對早期診斷重要性以及床邊超音波(POCUS)益處的認識不斷提高,加速全球對便攜式超音波產品的需求。
市場限制因子
先進設備成本高
儘管便攜式超音波設備便攜,但價格仍然昂貴。例如,根據 DRSONO2024年發布的資料,Tri-scan Max 設備的價格約為 3,599 美元。由於技術整合導致的高昂製造成本限制了其普及,尤其是在發展中國家。
此外,再生便攜式超音波掃描儀的價格更低。根據福斯科技股份有限公司2025年的資料,翻新的in-A5I手持式掃描儀的價格在1600美元至1800美元之間,這可能會降低對新系統的需求。
市場機會
新興經濟體醫療基礎設施的改善
中國、印度和巴西等國醫療支出的成長創造新的成長機會。根據美國國際貿易管理局(ITA)2023年的資料,巴西醫療保健支出佔其 GDP 的9.47%。
新興經濟體基礎設施的改善和研發投入的增加擴大先進成像系統的普及範圍,預計市場規模將從2026年的4.4828億美元進一步成長到2034年的11.3143億美元。
市場挑戰
監管和合規障礙
美國食品藥物管理局(FDA)和歐盟等機構的嚴格監管給製造商帶來了審批方面的挑戰。合規要求、設備安全標準和償付限制可能會延遲產品商業化。
市場趨勢
人工智慧(AI)整合
技術進步是塑造市場的主要趨勢。人工智慧和機器學習的整合提高了診斷準確性,實現了測量自動化,並提升了工作流程效率。
例如,2024年4月,GE醫療推出了整合CaptionAI軟體的Vscan Air SL手持式系統,可實現快速心臟評估。此類創新拓展臨床應用領域,包括放射學、心臟病學、婦科和肌肉骨骼影像學。
其他值得關注的趨勢包括:
依轉換器類型
市場細分為線陣、相控陣和其他類型。
依應用領域
應用領域包括放射科、婦科、心臟科和泌尿科。
依最終使用者劃分
最終使用者包括醫院、專科診所和影像診斷中心。
北美
北美將持續引領市場,2025年市場規模達到1.6315億美元。這一成長主要得益於美國人均醫療保健支出達到14,570美元(CMS2023)。
歐洲
由於人口老化加劇,預計歐洲市場將保持穩定成長。根據Centre for Ageing Better的資料,英國有超過1,000萬人年齡在65歲及以上。
亞太地區
預計亞太地區的成長率最高。根據美國國家生物技術資訊中心(NCBI,2023)的資料,中國約有 3.3億人患有心血管疾病,對診斷的需求不斷成長。
拉丁美洲、中東和非洲
由於醫療基礎設施的擴張,這些地區的市場成長。巴西擁有約 7,191 家醫院(ITA,2023),這為診斷影像設備的引進提供了支援。
The global handheld ultrasound market was valued at USD 397.29 million in 2025 and is projected to grow from USD 448.28 million in 2026 to USD 1,131.43 million by 2034, registering a strong CAGR of 12.27% during the forecast period (2026-2034). In 2025, North America dominated the market with a 41.07% share, reflecting strong adoption of point-of-care diagnostic technologies.
Handheld ultrasound devices are compact, portable imaging systems that connect to smartphones, tablets, or dedicated consoles. These devices enable rapid diagnostic decisions in hospitals, emergency settings, ambulatory care, and even home healthcare environments.
Market Overview
The increasing prevalence of acute and chronic disorders such as cardiovascular diseases, cancer, and urological conditions is a major growth driver. According to the World Health Organization (WHO), 20.0 million new cancer cases were reported globally in 2022, highlighting the growing demand for early and accessible diagnostic imaging solutions.
Additionally, the rising geriatric population is fueling demand. The U.S. Population Reference Bureau reported that 58.0 million Americans were aged 65 and above in 2022, a figure projected to reach 82 million by 2050. Aging populations are more susceptible to chronic illnesses, increasing the need for portable and cost-effective imaging tools.
Market Dynamics
Market Drivers
Rising Prevalence of Chronic and Acute Diseases
The growing burden of cardiovascular diseases significantly contributes to handheld ultrasound adoption. According to the CDC (2024), approximately 805,000 heart attacks occur annually in the U.S. The portability and real-time imaging capability of handheld systems make them highly suitable for cardiac assessments in emergency and intensive care settings.
Furthermore, growing awareness regarding early diagnosis and the benefits of point-of-care ultrasound (POCUS) are accelerating product demand globally.
Market Restraints
High Cost of Advanced Devices
Despite their portability, advanced handheld ultrasound devices remain expensive. For example, according to 2024 data published by DRSONO, the price of the Tri-scan Max device is approximately USD 3,599.0. High manufacturing costs due to technological integration limit adoption, particularly in developing countries.
Additionally, refurbished handheld ultrasound scanners are available at lower prices. As per 2025 data from Focus Technology Co., Ltd., refurbished in-A5I handheld scanners range between USD 1,600.0 and USD 1,800.0, which may reduce demand for new systems.
Market Opportunities
Improving Healthcare Infrastructure in Emerging Economies
Rising healthcare expenditure in countries such as China, India, and Brazil is creating new growth opportunities. According to the International Trade Administration (ITA) 2023 data, healthcare spending accounts for 9.47% of Brazil's GDP.
Improving infrastructure and growing R&D investments in emerging economies are expanding access to advanced imaging systems, further driving market growth from USD 448.28 million in 2026 to USD 1,131.43 million by 2034.
Market Challenges
Regulatory and Compliance Barriers
Stringent regulations from authorities such as the FDA and the European Union create approval challenges for manufacturers. Compliance requirements, device security standards, and reimbursement limitations can delay product commercialization.
Market Trends
Integration of Artificial Intelligence (AI)
Technological advancements are a key trend shaping the market. AI and machine learning integration enhance diagnostic accuracy, automate measurements, and improve workflow efficiency.
For instance, in April 2024, GE Healthcare launched CaptionAI software integrated into its Vscan Air SL handheld system to enable rapid cardiac assessments. Such innovations are expanding clinical applications across radiology, cardiology, gynecology, and musculoskeletal imaging.
Other notable trends include:
By Transducer Type
The market is segmented into linear, phased array, and others.
By Application
Applications include radiology, gynecology, cardiology, urology, and others.
By End User
End users include hospitals, specialty clinics, diagnostic imaging centers, and others.
North America
North America generated USD 163.15 million in 2025, maintaining market leadership. Growth is supported by high per capita healthcare expenditure, which reached USD 14,570.0 in the U.S. (CMS 2023).
Europe
Europe is expected to grow steadily due to rising geriatric populations. According to 2025 data from the Centre for Ageing Better, over 10 million people aged 65+ live in the U.K.
Asia Pacific
Asia Pacific is projected to witness the highest growth rate. According to NCBI (2023), approximately 330 million individuals in China suffer from cardiovascular diseases, increasing diagnostic demand.
Latin America & Middle East & Africa
These regions are growing due to healthcare infrastructure expansion. Brazil has approximately 7,191 hospitals (ITA 2023), supporting imaging adoption.
Competitive Landscape
The market is semi-consolidated with key players such as GE Healthcare, Philips, Butterfly Network, Shenzhen Mindray, Clarius, and Konica Minolta. Companies focus on AI integration, wireless technology, and product launches to strengthen their market positions.
Recent developments include:
Conclusion
The global handheld ultrasound market is set for significant expansion, increasing from USD 397.29 million in 2025 to USD 1,131.43 million by 2034. Growth is driven by rising chronic disease prevalence, increasing geriatric populations, AI-driven technological advancements, and expanding healthcare infrastructure in emerging markets. Although high device costs and regulatory complexities present challenges, strong innovation and growing point-of-care adoption are expected to sustain long-term market growth worldwide.
Segmentation By Transducer Type
By Application
By End User
By Region